Gabelli Healthcare & WellnessRx Trust (GRX)
9.83
-0.01
(-0.10%)
USD |
NYSE |
Mar 28, 16:00
9.82
-0.01
(-0.10%)
Pre-Market: 20:00
Key Stats
| Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 3.11% | -16.05% | 200.33M | 29473.77 |
| Dividend Yield | Turnover Ratio | 1 Year Fund Level Flows | Max Drawdown (All) |
| 6.10% | 14.00% | 18.85M | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund's investment objective is long term growth of capital. The Fund will invest at least 80% of its assets, under normal market conditions, in equity securities and income producing securities of domestic and foreign companies in the healthcare and wellness industries. |
| General | |
| Security Type | Closed-End Fund |
| Equity Style | Mid Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Category Index | S&P 1500 Health Care TR |
| Global Category Name | Healthcare Sector Equity |
| YCharts Categorization | Healthcare Equity |
| YCharts Benchmark | S&P 1500 Health Care (Sector) Total Return (^SP15HCSTR) |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | Gabelli |
| Prospectus Benchmark Index | |
| S&P Health Care Select Sector TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
| Manager Tenure | |
| Mario Gabelli | 15.68 yrs |
| Jeffrey Jonas | 12.71 yrs |
| Kevin Dreyer | 12.71 yrs |
| Jennie Tsai | 2.16 yrs |
| Sara Wojda | 2.16 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
14
18.85M
-2.719B
Category Low
6.230B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of January 31, 2012
Risk
Performance Versus Category
As of March 28, 2023. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of March 28, 2023.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| CVS Health Corp | 3.84% | 73.12 | -0.61% |
| Nestle SA | 3.16% | 119.95 | 0.34% |
|
United States Treasury Bills 4.19281%
|
2.87% | -- | -- |
| AbbVie Inc | 2.87% | 158.25 | 0.45% |
| The Cigna Group | 2.79% | 256.50 | -2.02% |
| Johnson & Johnson | 2.69% | 151.82 | -0.97% |
| HCA Healthcare Inc | 2.47% | 254.48 | 0.03% |
| Tenet Healthcare Corp | 2.14% | 54.96 | -0.38% |
| Chemed Corp | 2.11% | 528.99 | 0.49% |
| Option Care Health Inc | 2.05% | 31.65 | 0.29% |
News
Headline
Wire
Time (ET)
Yahoo
02/17 08:00
Yahoo
01/18 09:38
MT Newswires
08/18 07:40
MT Newswires
08/20 09:22
MT Newswires
08/20 05:12
Basic Info
| Investment Strategy | |
| The Fund's investment objective is long term growth of capital. The Fund will invest at least 80% of its assets, under normal market conditions, in equity securities and income producing securities of domestic and foreign companies in the healthcare and wellness industries. |
| General | |
| Security Type | Closed-End Fund |
| Equity Style | Mid Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Category Index | S&P 1500 Health Care TR |
| Global Category Name | Healthcare Sector Equity |
| YCharts Categorization | Healthcare Equity |
| YCharts Benchmark | S&P 1500 Health Care (Sector) Total Return (^SP15HCSTR) |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | Gabelli |
| Prospectus Benchmark Index | |
| S&P Health Care Select Sector TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
| Manager Tenure | |
| Mario Gabelli | 15.68 yrs |
| Jeffrey Jonas | 12.71 yrs |
| Kevin Dreyer | 12.71 yrs |
| Jennie Tsai | 2.16 yrs |
| Sara Wojda | 2.16 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (3-28-23) | 6.10% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 19.80 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of December 31, 2022
Fund Details
| Key Dates | |
| Inception Date | 6/19/2007 |
| Last Annual Report Date | 12/31/2022 |
| Last Prospectus Date | 12/31/2013 |
| Attributes | |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund |
|
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan |
|
| Socially Responsible Fund | No |
News
Headline
Wire
Time (ET)
Yahoo
02/17 08:00
Yahoo
01/18 09:38
MT Newswires
08/18 07:40
MT Newswires
08/20 09:22
MT Newswires
08/20 05:12